162 related articles for article (PubMed ID: 25461891)
21. Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors.
Zhang Q; Jiang ZY; Luo J; Ma YB; Liu JF; Guo RH; Zhang XM; Zhou J; Niu W; Du FF; Li L; Li C; Chen JJ
Bioorg Med Chem Lett; 2009 Dec; 19(23):6659-65. PubMed ID: 19853440
[TBL] [Abstract][Full Text] [Related]
22. Isolation and structure of vanitaracin A, a novel anti-hepatitis B virus compound from Talaromyces sp.
Matsunaga H; Kamisuki S; Kaneko M; Yamaguchi Y; Takeuchi T; Watashi K; Sugawara F
Bioorg Med Chem Lett; 2015 Oct; 25(19):4325-8. PubMed ID: 26271586
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents.
Chen H; Ma YB; Huang XY; Geng CA; Zhao Y; Wang LJ; Guo RH; Liang WJ; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2014 May; 24(10):2353-9. PubMed ID: 24731274
[TBL] [Abstract][Full Text] [Related]
24. Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
Qu SJ; Wang GF; Duan WH; Yao SY; Zuo JP; Tan CH; Zhu DY
Bioorg Med Chem; 2011 May; 19(10):3120-7. PubMed ID: 21524588
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiviral effects of isosteviol-derived analogues against the hepatitis B virus.
Huang TJ; Chou BH; Lin CW; Weng JH; Chou CH; Yang LM; Lin SJ
Phytochemistry; 2014 Mar; 99():107-14. PubMed ID: 24461778
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of helioxanthin analogues.
Janmanchi D; Lin CH; Hsieh JY; Tseng YP; Chen TA; Jhuang HJ; Yeh SF
Bioorg Med Chem; 2013 Apr; 21(7):2163-76. PubMed ID: 23465436
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
31. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors.
Zhang H; Lu G
Chem Biol Drug Des; 2020 Dec; 96(6):1380-1386. PubMed ID: 32573976
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.
Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP
J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and in-vitro anti-hepatitis-B virus activity of 6H-[1]benzothiopyrano[4,3-b] quinolin-10-ols.
Jia W; Zhao Y; Li R; Wu Y; Li Z; Gong P
Arch Pharm (Weinheim); 2009 Sep; 342(9):507-12. PubMed ID: 19637181
[TBL] [Abstract][Full Text] [Related]
36. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
[TBL] [Abstract][Full Text] [Related]
37. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.
Wang XY; Wei ZM; Wu GY; Wang JH; Zhang YJ; Li J; Zhang HH; Xie XW; Wang X; Wang ZH; Wei L; Wang Y; Chen HS
Antivir Ther; 2012; 17(5):793-803. PubMed ID: 22668794
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anti-hepatitis B activity of new substituted uracil and thiouracil glycosides.
Abdel-Aal MT
Arch Pharm Res; 2010 Jun; 33(6):797-805. PubMed ID: 20607483
[TBL] [Abstract][Full Text] [Related]
39. Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.
Zhang Q; Jiang ZY; Luo J; Cheng P; Ma YB; Zhang XM; Zhang FX; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4647-50. PubMed ID: 18644720
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of novel 2'-deoxy-2'-fluoro-2'-C-methyl 8-azanebularine derivatives as potent anti-HBV agents.
Yang W; Peng Y; Wang J; Song C; Yu W; Zhou Y; Jiang J; Wang Q; Wu J; Chang J
Bioorg Med Chem Lett; 2019 Jun; 29(11):1291-1297. PubMed ID: 30962085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
